Prognostic biomarkers and molecular targets provide treatment options for patients with metastatic/advanced melanoma; however, acquired resistance to some drugs still proves challenging.
Advanced, metastatic melanoma is an aggressive disease with a poor prognosis; but therapies targeting gene mutations may offer hope to some patients.
Immunotherapies are offering new hope to patients with advanced metastatic melanoma.
Melanoma is one of the fastest growing cancers, but it can be prevented. Patients can use these tips to decrease the risk of skin cancer.
This patient fact sheet describes the risk factors for and preventative measures to take against melanoma.
Help your patients learn what they can do to protect themselves from skin cancer with this patient fact sheet.
Two research teams find genes that may contribute to the development of melanoma and make it more resistant to treatment.
C. Andrew Kistler, MD, PharmD, RPh, discusses how severe GI symptoms caused by ipilimumab can best be managed.
Advisory Board Member Dr. Farma reviews the current recommendations for using sentinel lymph node biopsy in patients with melanoma.
Regardless of the efforts you might be making to prevent your patients from developing skin cancer, people are becoming habitual tanners in droves.
Melanoma is the most dangerous type of skin cancer, and the most deadly. It begins in the melanocytes, but may ...
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|